CN Patent

CN105878201A — 托匹司他延长释放制剂

Assigned to Shandong Ruihe Pharmaceutical R&d Co Ltd · Expires 2016-08-24 · 10y expired

What this patent protects

本发明提供了一种调节血液尿酸水平的缓释制剂药物组合物及其制备方法。其特征在于该组合物包含托匹司他、亲水凝胶型缓释骨架材料及药学上可接受的赋形剂。其在24小时时段中提供延长的治疗有效的血浆水平并通过消除患者血浆中药物浓度的峰‑谷现象而减少不良反应的发生率。通过湿法制粒、干法制粒或直接压片制备本品。

USPTO Abstract

本发明提供了一种调节血液尿酸水平的缓释制剂药物组合物及其制备方法。其特征在于该组合物包含托匹司他、亲水凝胶型缓释骨架材料及药学上可接受的赋形剂。其在24小时时段中提供延长的治疗有效的血浆水平并通过消除患者血浆中药物浓度的峰‑谷现象而减少不良反应的发生率。通过湿法制粒、干法制粒或直接压片制备本品。

Drugs covered by this patent

Patent Metadata

Patent number
CN105878201A
Jurisdiction
CN
Classification
—
Expires
2016-08-24
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Ruihe Pharmaceutical R&d Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.